IC-MPGN

Clinical trials for IC-MPGN explained in plain language.

Never miss a new study

Get alerted when new IC-MPGN trials appear

Sign up with your email to follow new studies for IC-MPGN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 2 Completed 1

Hope for rare kidney patients: new drug shows promise in phase 3 trial

Disease control Completed

This study tested a drug called pegcetacoplan in 124 adults and teens with two rare kidney diseases (C3G and IC-MPGN). The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage, compared to a placebo. Participants received injections twice a week …

Matched conditions: IC-MPGN

Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 17, 2026 10:06 UTC

IC-MPGN

Get alerted when new IC-MPGN trials appear

Hope for rare kidney patients: new drug shows promise in phase 3 trial